Ranbaxy Laboratories
BSE: 500359 | NSE: RANBAXY | ISIN: INE015A01028 | Pharmaceuticals
Nine Months of Ranbaxy Laboratories |
------------------- in Rs. Cr. ------------------- |
 |
|
|
Sep '05 |
Sep '06 |
Sep '07 |
Sep '08 |
Sep '09 |
|
| Sales Turnover |
2,540.91 |
2,919.56 |
3,040.92 |
3,518.00 |
3,268.37 |
| Other Income |
180.81 |
54.66 |
522.01 |
29.47 |
149.89 |
| Total Income |
2,721.72 |
2,974.22 |
3,562.93 |
3,547.46 |
3,418.25 |
| Total Expenses |
2,500.94 |
2,539.57 |
2,712.93 |
3,576.28 |
3,175.02 |
| Operating Profit |
39.97 |
379.99 |
327.99 |
-58.28 |
93.35 |
| Profit On Sale Of Assets |
-- |
-- |
-- |
-- |
-- |
| Profit On Sale Of Investments |
-- |
-- |
-- |
-- |
-- |
| Gain/Loss On Foreign Exchange |
-- |
-- |
-- |
-- |
-- |
| VRS Adjustment |
-- |
-- |
-- |
-- |
-- |
| Other Extraordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Total Extraordinary Income/Expenses |
-- |
-22.60 |
31.38 |
-154.62 |
-- |
| Tax On Extraordinary Items |
-- |
-- |
-- |
-- |
-- |
| Net Extra Ordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Gross Profit |
220.78 |
434.65 |
850.00 |
-28.81 |
243.24 |
| Interest |
19.56 |
44.50 |
66.77 |
109.11 |
33.99 |
| PBDT |
201.22 |
367.55 |
814.61 |
-292.55 |
198.98 |
| Depreciation |
74.29 |
86.30 |
89.00 |
91.64 |
92.22 |
| Depreciation On Revaluation Of Assets |
-- |
-- |
-- |
-- |
-- |
| PBT |
126.93 |
281.25 |
725.61 |
-384.19 |
106.76 |
| Tax |
-6.50 |
33.87 |
151.02 |
-158.41 |
23.01 |
| Net Profit |
133.43 |
247.38 |
574.59 |
-225.78 |
83.75 |
| Prior Years Income/Expenses |
-- |
-- |
-- |
-- |
-10.26 |
| Depreciation for Previous Years Written Back/ Provided |
-- |
-- |
-- |
-- |
-- |
| Dividend |
-- |
-- |
-- |
-- |
-- |
| Dividend Tax |
-- |
-- |
-- |
-- |
-- |
| Dividend (%) |
-- |
-- |
-- |
-- |
-- |
| Earnings Per Share |
3.58 |
6.64 |
15.41 |
-- |
1.99 |
| Book Value |
-- |
-- |
-- |
-- |
-- |
| Equity |
186.20 |
186.33 |
186.48 |
187.04 |
210.19 |
| Reserves |
-- |
-- |
-- |
-- |
-- |
| Face Value |
5.00 |
5.00 |
5.00 |
5.00 |
5.00 |
|
|
|
|
| Source : Religare Technova |
| Explore Ranbaxy Labs connections |
|
